Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture

被引:26
作者
Jones, TR
Gramzinski, RA
Aguiar, JC
Sim, BKL
Narum, DL
Fuhrmann, SR
Kumar, S
Obaldia, N
Hoffman, SL
机构
[1] USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA
[2] Pan Amer Hlth Org, Washington, DC USA
[3] EntreMed Inc, Rockville, MD USA
[4] Promed Trading SA, Panama City, Panama
[5] Gorgas Mem Inst, Panama City, Panama
关键词
malaria; immunization; DNA vaccines;
D O I
10.1016/S0264-410X(01)00513-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aotus lemurinus lemurinus monkeys were immunized four times with one of three DNA plasmids expressing important Plasmodium falciparum blood stage vaccine candidate proteins or with a mixture containing all three vaccines. The three vaccines encoded sequences from apical merozoite antigen-1 (AMA-1), erythrocyte binding protein-175 (EBA-175) and merozoite surface protein-1 (MSP-1). Antigen-specific enzyme-linked immunosorbant assays (ELISAs) showed no significant differences in antibody titer induced to the three antigens by a single vaccine compared with the titer induced to that same antigen by the trivalent preparation. Results of immunofluorescent antibody assays against erythrocytes infected with asexual blood stage P. falciparum indicated that each of the three monovalent vaccines induced significant antibody responses to whole parasites. The trivalent vaccine mixture induced, after four immunizations, an antibody titer to whole parasites that was 3-12-fold higher than those induced by any of the single vaccines. The fourth immunization with the trivalent vaccine increased the mean antibody in IFAT by more than five-fold. Published by Elsevier Science Ltd.
引用
收藏
页码:1675 / 1680
页数:6
相关论文
共 29 条
[1]   Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device [J].
Aguiar, JC ;
Hedstrom, RC ;
Rogers, WO ;
Charoenvit, Y ;
Sacci, JB ;
Lanar, DE ;
Majam, VF ;
Stout, RR ;
Hoffman, SL .
VACCINE, 2001, 20 (1-2) :275-280
[2]   Protection of mice against Plasmodium yoelii sporozoite challenge with P-yoelii merozoite surface protein 1 DNA vaccines [J].
Becker, SI ;
Wang, RB ;
Hedstrom, RC ;
Aguiar, JC ;
Jones, TR ;
Hoffman, SL ;
Gardner, MJ .
INFECTION AND IMMUNITY, 1998, 66 (07) :3457-3461
[4]   A recombinant Baculovirus 42-kilodalton c-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria [J].
Chang, SP ;
Case, SE ;
Gosnell, WL ;
Kramer, KJ ;
Tam, LQ ;
Hashiro, CQ ;
Nikaido, CM ;
Gibson, HL ;
LeeNg, CT ;
Barr, PJ ;
Yokota, BT ;
Hui, GSN .
INFECTION AND IMMUNITY, 1996, 64 (01) :253-261
[5]   Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes [J].
Charoenvit, Y ;
Fallarme, V ;
Rogers, WO ;
Sacci, JB ;
Kaur, M ;
Aguiar, JC ;
Yuan, LF ;
Corradin, G ;
Andersen, E ;
Wizel, B ;
Houghten, RA ;
Oloo, A ;
DelaVega, P ;
Hoffman, SL .
INFECTION AND IMMUNITY, 1997, 65 (08) :3430-3437
[6]   VACCINATION TRIALS IN RHESUS-MONKEYS WITH A MINOR, INVARIANT, PLASMODIUM-KNOWLESI 66 KD MEROZOITE ANTIGEN [J].
DEANS, JA ;
KNIGHT, AM ;
JEAN, WC ;
WATERS, AP ;
COHEN, S ;
MITCHELL, GH .
PARASITE IMMUNOLOGY, 1988, 10 (05) :535-552
[7]   Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8(+) T cell-, interferon gamma-, and nitric oxide-dependent immunity [J].
Doolan, DL ;
Sedegah, M ;
Hedstrom, RC ;
Hobart, P ;
Charoenvit, Y ;
Hoffman, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1739-1746
[8]   Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys [J].
Egan, AF ;
Blackman, MJ ;
Kaslow, DC .
INFECTION AND IMMUNITY, 2000, 68 (03) :1418-1427
[9]   Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines [J].
Fattom, A ;
Cho, YH ;
Chu, CY ;
Fuller, S ;
Fries, L ;
Naso, R .
VACCINE, 1999, 17 (02) :126-133
[10]  
Grifantini R, 1998, EUR J IMMUNOL, V28, P1225, DOI 10.1002/(SICI)1521-4141(199804)28:04<1225::AID-IMMU1225>3.0.CO